KLK3, kallikrein related peptidase 3, 354

N. diseases: 358; N. variants: 19
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0003469
Disease: Anxiety Disorders
Anxiety Disorders
0.100 AlteredExpression group BEFREE The patients' most recent prostate-specific antigen (PSA) levels and hormonal symptoms were key predictors of their anxiety and depression levels. 28921733 2018
CUI: C0003469
Disease: Anxiety Disorders
Anxiety Disorders
0.100 Biomarker group BEFREE Patients with lower relationship satisfaction experienced lower positive affect (β = 0.279) and higher negative affect (β = -0.323), and their partners experienced higher prostate specific antigen-related anxiety (β = -0.014). 30473044 2018
CUI: C0003469
Disease: Anxiety Disorders
Anxiety Disorders
0.100 Biomarker group BEFREE Some items related to the repetition of the PSA test showed a large floor effect and thus were poorly effective in measuring anxiety for PSA testing in patients on AS. 28623635 2018
CUI: C0003469
Disease: Anxiety Disorders
Anxiety Disorders
0.100 Biomarker group BEFREE Primary intervention outcomes were psychological distress, cancer-specific distress, and prostate-specific antigen anxiety. 27870567 2017
CUI: C0003469
Disease: Anxiety Disorders
Anxiety Disorders
0.100 Biomarker group BEFREE The final model explained 12% of the variance for PSA anxiety and 24% for PC anxiety. 28528448 2017
CUI: C0003469
Disease: Anxiety Disorders
Anxiety Disorders
0.100 Biomarker group BEFREE In order to investigate the initial and late effects of PSA tests on psychological distress during serial measurements, two groups of men with screen-positive results (PSA ≥3 ng/ml) were studied-205 men whose first questionnaires regarding anxiety and depression were taken at initial screening (group A), and 103 men whose questionnaires were taken at repeated measurement for prior PSA elevation (group B). 27631094 2017
CUI: C0003469
Disease: Anxiety Disorders
Anxiety Disorders
0.100 Biomarker group BEFREE Anxiety about prostate specific antigen testing was rare. 27943512 2017
CUI: C0003469
Disease: Anxiety Disorders
Anxiety Disorders
0.100 Biomarker group BEFREE There was no difference in anxiety scores at biopsy between men with or without a family history of prostate cancer (p=0.68), or between those with a raised PSA of 10-<20ng/ml compared to a PSA result of 3-<10ng/ml (p=0.46). 19375907 2009
CUI: C0003469
Disease: Anxiety Disorders
Anxiety Disorders
0.100 GeneticVariation group BEFREE Exposure to stressors during juvenility disrupts development-related alterations in the PSA-NCAM to NCAM expression ratio: potential relevance for mood and anxiety disorders. 17429411 2008
CUI: C0003469
Disease: Anxiety Disorders
Anxiety Disorders
0.100 Biomarker group BEFREE To describe the impact of prostate-specific antigen (PSA) screening on the health-related quality of life (HRQOL) and anxiety of men with a family history of prostate cancer. 12031378 2002